Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 12:56 pm Purchase |
2021-12-31 | 13G | Bionomics Limited BNOX |
BIOTECHNOLOGY VALUE FUND L P | 14,174,157 13.000% |
14,174,157 (New Position) |
Filing History |
| 2022-02-14 12:53 pm Purchase |
2021-12-31 | 13G | GH Research PLC GHRS |
BIOTECHNOLOGY VALUE FUND L P | 9,275,158 17.800% |
9,275,158 (New Position) |
Filing History |
| 2022-02-11 9:11 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.600% |
1,136,363 (+30.53%) |
Filing History |
| 2022-02-11 9:03 pm Purchase |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 4,891,945 9.990% |
616,980 (+14.43%) |
Filing History |
| 2022-02-11 8:57 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 1,810,549 2.500% |
-1,946,500 (-51.81%) |
Filing History |
| 2022-02-11 8:51 pm Purchase |
2021-12-31 | 13G | POINT Biopharma Global Inc. PNT |
BIOTECHNOLOGY VALUE FUND L P | 2,920,526 3.200% |
2,920,526 (New Position) |
Filing History |
| 2022-02-11 8:33 pm Purchase |
2021-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 14,360,000 9.600% |
3,397,000 (+30.99%) |
Filing History |
| 2022-02-11 8:19 pm Sale |
2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 559 1.000% |
-1,787,000 (-99.97%) |
Filing History |
| 2022-02-11 7:54 pm Purchase |
2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
BIOTECHNOLOGY VALUE FUND L P | 5,930,353 9.990% |
644,804 (+12.20%) |
Filing History |
| 2022-02-11 7:44 pm Sale |
2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,695,418 (Position Closed) |
Filing History |
| 2022-02-11 7:41 pm Sale |
2021-12-31 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-53,770 (Position Closed) |
Filing History |
| 2022-02-11 7:33 pm Sale |
2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
BIOTECHNOLOGY VALUE FUND L P | 899,392 4.300% |
-247,660 (-21.59%) |
Filing History |
| 2022-02-11 7:30 pm Sale |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
BIOTECHNOLOGY VALUE FUND L P | 1,370,947 3.000% |
-1,527,850 (-52.71%) |
Filing History |
| 2022-02-11 7:22 pm Sale |
2021-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.600% |
-925,000 (-18.28%) |
Filing History |
| 2022-01-31 5:07 pm Purchase |
2022-01-27 | 13D | Kymera Therapeutics, Inc. KYMR |
BIOTECHNOLOGY VALUE FUND L P | 3,586,658 7.000% |
955,996 (+36.34%) |
Filing History |
| 2022-01-28 4:35 pm Purchase |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% |
878,690 (+60.68%) |
Filing History |
| 2022-01-24 5:23 pm Purchase |
2022-01-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.300% |
3,868,043 (New Position) |
Filing History |
| 2022-01-18 5:18 pm Purchase |
2022-01-07 | 13G | Sutro Biopharma, Inc. STRO |
BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.800% |
1,306,254 (+70.45%) |
Filing History |
| 2022-01-12 5:05 pm Purchase |
2022-01-10 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,526,282 14.100% |
1,425,000 (+45.95%) |
Filing History |
| 2022-01-12 5:03 pm Purchase |
2021-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 3,101,282 9.700% |
602,381 (+24.11%) |
Filing History |